I watched the interview.
It's interesting, but it is still way too early as it's on pre-clinical stage.
It would take another 8 years to complete 3 phase trials providing no failures on every phase.
I don't think many IPO subscribers would wait that long, just take profit and run, imo.
ARGENICA THERAPEUTICS LIMITED IPO Analysis, page-4
-
- There are more pages in this discussion • 87 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.5¢ |
Change
-0.030(3.64%) |
Mkt cap ! $101.0M | |||
| Open | High | Low | Value | Volume |
| 82.0¢ | 82.0¢ | 78.5¢ | $53.83K | 67.44K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 17435 | 78.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 6600 | 1 |
View Market Depth
| Last trade - 13.08pm 18/09/2024 (20 minute delay) ? |
| AGN (ASX) Chart |